Investment
Features
FeesSafety
Academy
More
Pluang+

Edge Total Intelligence grants Lotus Domaine III LP board seats and investor rights in new agreement

Company Fundamentals
23 Sep 2026
Newsfile Corp
View Source
Neutral
Edge Total Intelligence grants Lotus Domaine III LP board seats and investor rights in new agreement

Edge Total Intelligence Inc. has entered into an investor rights agreement with Lotus Domaine III LP, granting Lotus the right to nominate three board members and maintain a pro rata interest if holding at least 15% of shares. The agreement restricts the company from nominating more than seven directors without Lotus's consent and includes pre-emptive rights for Lotus in future financings. These rights will end upon the company's initial listing on a major U.S. stock exchange or its first underwritten public offering. The company also updated its board nominations accordingly and extended the proxy submission deadline for its upcoming shareholder meeting.

Edge Total Intelligence's recent investor rights agreement is presented here with Pluang's Technology-sector snapshot as of Sep 23, 2026 23:05 WIB: Among 150 priced US tech stocks, 74 rose and 76 fell. Notable movers include IONQ Inc at USD 42.79 (+5.03%), Crowdstrike Holdings Inc at USD 262.61 (+5.02%), and Aehr Test Systems at USD 95.84 (-4.73%). Typical hold times range from 13 to 96 days, with varying buy/sell order activity ratios.

More News

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

Jefferies analysts set a new price target of $435 for General Electric Aerospace, implying a 35% upside from its current price of around $321. GE Aerospace's strong position is supported by a $170 billion commercial services backlog and 80,000 aircra...

Analyst Insights
Bullish
1 hour ago
BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas lowered its price target for PepsiCo from $183 to $161 on September 23, 2026, due to ongoing demand challenges in North America. Despite the cut, the firm maintained an Outperform rating, indicating confidence in the stock's potential. Th...

Analyst Insights
Bearish
2 hours ago
Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex Therapeutics saw its price target raised from $70 to $88 by Leerink Partners following successful Phase III trial results for its drug barzolvolimab treating chronic spontaneous urticaria (CSU). The trials met all primary endpoints, showing l...

Analyst Insights
Bullish
2 hours ago
Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper, a major copper producer, shows stock volatility between $16.88 and $40.83 over the past year. Analyst firm CIBC maintained a "Neutral" rating but increased the price target to C$56.00, reflecting optimism about the company's long-term gro...

Analyst Insights
Bullish
3 hours ago
Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas Corporation posted robust first-quarter results, surpassing analyst expectations with earnings per share of $1.39 and revenue of $3.01 billion, a 10.9% increase year-over-year. The company's organic revenue growth was 8.9%, reflecting solid bu...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App